ABSTRACT
INTRODUCTION
The management of acute postoperative pain remains a priority for patients and health care professionals; however, successful postoperative pain management continues to be challenging [1, 2] . Patient-controlled analgesia (PCA) was introduced in the late 1970s to improve postoperative pain management [3, 4] . It has been demonstrated that patients who receive PCA versus non-PCA analgesia have better pain control and are more satisfied with their method of pain control [5, 6] . New approaches, such as multimodal analgesia and enhanced recovery after surgery (ERAS) protocols, have been introduced to improve pain management and patient outcomes in the postoperative setting. At the same time, patients who are presenting for surgery have more co-morbidities (e.g., obesity) that make surgery and postoperative care more challenging. In addition, the US Additionally, per the Prescribing Information, fentanyl ITS is to be used after patients have been titrated to an acceptable level of analgesia, typically using alternate opioid analgesics.
While in clinical development, fentanyl ITS was studied in seven phase III placebo and active-controlled clinical trials [8] [9] [10] [11] [12] [13] [14] . In the active-comparator trials, fentanyl ITS was comparable to morphine IV PCA in terms of pain-control efficacy and safety and was superior for ease of care and nursing and patient satisfaction [8, [10] [11] [12] .
The objective of this case series was to examine the ''real-world'' usage of the recently approved fentanyl ITS. It is important to note that, while this case series includes an evaluation of surgical types that would have fit the clinical study inclusion/exclusion criteria but may not have been specifically enrolled in the original clinical trials (i.e., bariatric surgery), fentanyl ITS is indicated across surgery types, and all cases were managed consistent with the Prescribing Information. This case series provides an opportunity to review experiences of early users of fentanyl ITS across a variety of surgical and patient types in a clinical practice setting.
METHODS
A systematic retrospective review of each patient chart using a predefined set of variables was 
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RESULTS
This report includes seven cases from three sites. and then discontinued; the three devices were applied to the upper arm on alternate sides. At that point, she was transitioned to oral (PO) hydrocodone/acetaminophen. The patient received no additional opioids while on fentanyl ITS. Throughout her stay, her diet was uneventfully advanced from clear liquids to full liquids, and then solids. There was some slight skin redness where the system had been applied, but it resolved without intervention by the next day. On POD 7 she underwent a percutaneous coronary intervention for further work-up of her silent MI. She was discharged on POD 8. The patient's general impression of fentanyl ITS was that she was very happy with the method of pain control.
Case 5
A 63-year-old male patient (BMI 28 kg/m 2 ) with a painful perirectal abscess (right posterolateral, multiloculated) was seen in the emergency room and underwent emergent surgery that evening, which involved an incision and drainage of the abscess with 150 ml of pus drained. He had a history of diabetes and thyroid disease. In the PACU, he received 100 mcg of fentanyl. He was transferred to the medical-surgical unit where the patient was trained on fentanyl ITS use and the system was applied to the upper arm. No other pain medications were used. Although the skin was normal, the system initially did not have good contact and then was successfully readjusted and adherence was then fine. Once the system was readjusted, his pain level quickly improved. The patient used two fentanyl ITS systems. On POD 1, the patient administered 19 doses of fentanyl; the number of doses decreased on POD 2, and the fentanyl ITS was used for most of that day and then discontinued. There was some slight skin redness at both administration sites where the system had been applied, but resolved without intervention within 24 h. The patient was then transitioned to PO hydrocodone/acetaminophen. On POD 4, the patient was discharged. The patient reported that he was very satisfied with the pain control that the system provided once it was adhered to his skin. 
CLINICAL PRACTICE INSIGHTS AND HELPFUL HINTS

Ease-of-Use
Overall, the clinicians interviewed felt that fentanyl ITS was easy to use for their patients.
The patients in this case series consistently reported to their clinician that the product was easy to use. Nurses expressed relief at not having to program PCA settings or manage an additional IV line (or any IV line). One site also indicated that the use of fentanyl ITS with its fixed dosing is an asset as it eliminated unnecessary programming and variability in postoperative pain management. In addition, the physical therapists (physiotherapists) managing the prostate surgery patients noted that mobilizing patients was much easier without an IV line. Fentanyl ITS also reduced issues with IV access and workload associated with IV PCA devices.
Training
The sites emphasized the importance of staff training on how to manage the system. Six of the seven cases were elective or semi-elective surgeries; the perirectal abscess case was an emergent case performed at night.
This case was also managed successfully with fentanyl ITS and showed that training the staff in advance can enable appropriate use of the device in surgeries that are not pre-planned.
Titration to Comfort before Initiating Fentanyl ITS
It was repeatedly noted that patients responded better to fentanyl ITS if they were titrated to comfort prior to initiation, which is consistent with the Prescribing Information for fentanyl ITS. These clinicians initiated fentanyl ITS on the medical-surgical unit because they found that patients in the PACU may be too sedated to understand or operate the system, although the system can be applied in the PACU or on the patient floor.
Breakthrough Pain
In this series, most patients did not require additional analgesic medication during fentanyl ITS administration; however, the sites reported that it is worthwhile to have PRN orders of opioids and/or NSAIDs to assist with breakthrough pain in case it is required.
However, it is important to remember that the concomitant use of fentanyl ITS with other central nervous system depressants can increase the risk of respiratory depression and therefore the clinicians must monitor patients even more closely if using a concomitant opioid.
Medication after Fentanyl ITS
Once patients were able to progress beyond parenteral opioids, they were easily transitioned from fentanyl ITS to the clinician's standard pre-discharge oral analgesia regimen. Most were switched to the combination of hydrocodone and acetaminophen. This allowed fentanyl ITS to be readily incorporated into each center's standard-of-care pain management regimen.
Application Site
When applying fentanyl ITS, it is important to press and hold the system firmly in place, with the sticky side down, onto the patient's skin for at least 15 s. However, occasionally, the system may loosen from the skin and if this occurs, it should be secured to the patient's skin by pressing the edges with fingers or securing with a non-allergenic tape to make sure that all edges have complete contact with the skin. It is important to remember not to place tape over the button, light, or digital display.
Application Site Skin Reactions
Consistent with the fentanyl ITS Prescribing Information, some patients experienced redness at the application site. In this case series, none of the site reactions were severe; none required intervention or discontinuation of the product.
It is important to train and alert the clinical staff that this can be an adverse event associated with fentanyl ITS use; however, it is typically self-limited. 
DISCUSSION
